Tenaya Therapeutics (TNYA) Non Operating Income (2020 - 2026)

Tenaya Therapeutics' Non Operating Income history runs 7 years deep, the most recent figure standing at $793000.0 for Q1 2026.

• On a quarterly basis, Non Operating Income rose 17.66% year-over-year to $793000.0 in Q1 2026; TTM through Mar 2026 was $2.9 million, a 27.94% decrease from a year earlier, with the FY2025 full-year figure at $2.7 million, down 43.27% from the prior year.
• Non Operating Income advanced to $793000.0 in Q1 2026 per TNYA's latest filing, from $600000.0 in the prior quarter.
• Across five years, Non Operating Income topped out at $2.0 million in Q1 2023 and bottomed at $98000.0 in Q1 2022.
• The 5-year median for Non Operating Income is $816000.0 (2024), against an average of $1.0 million.
• Across the five-year window, Non Operating Income soared 7853.85% in 2022 and slumped 56.06% in 2025, its largest moves.
• Year by year, Non Operating Income stood at $1.0 million in 2022, then jumped by 46.13% to $1.5 million in 2023, then plunged by 46.0% to $816000.0 in 2024, then slipped by 26.47% to $600000.0 in 2025, then jumped by 32.17% to $793000.0 in 2026.
• Per Business Quant, the three latest TNYA Non Operating Income figures stand at $793000.0 (Q1 2026), $600000.0 (Q4 2025), and $661000.0 (Q3 2025).